View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 27, 2017

Velano’s PIVO blood draw device secures third FDA 510(k) clearance

Medical device company Velano Vascular's needle-free blood draw device PIVO has secured 510(k) clearance from the US Food and Drug Administration (FDA).

Medical device company Velano Vascular's needle-free blood draw device PIVO has secured 510(k) clearance from the US Food and Drug Administration (FDA).

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

PIVO is a single-use, disposable device developed to provide consistent, quality blood samples from indwelling peripheral IV lines, in addition to minimising the repeated needle sticks and central line access for blood collection.

Designed for ease-of-use and high volume manufacturing, the new device aims at decreasing risk for both patients and practitioners.

"Through the new device, the firm intends to enable hospitals to better serve patients with difficult venous access."

Velano Vascular chief executive Eric Stone said: “The deliberate and thoughtful design inputs for the next generation of PIVO reflect our commitment to rapid product development cycles informed by real world experience in the country’s leading health systems.

“Feedback from hundreds of practitioners already using our technology reinforced PIVO’s ability to enhance the blood draw experience for patients and clinical staff, and helped us to develop a next generation product better suited for widespread adoption.”

Through the new device, the firm intends to enable hospitals to better serve patients with difficult venous access (DVA), along with offering a financially responsible alternative for health systems.

It is expected that the improvement of usability and accessibility of the PIVO may attain its potential for global standard of care.

Currently in use at multiple health systems in the US, Velano plans to expand the availability of the device this year after this clearance for the second generation PIVO solution.

The frim focuses on minimising the pain, risk and inefficiencies of vascular access and blood collection practices.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network